Glucotrack (GCTK) Cash from Investing Activities Growth (3y) (2013 - 2025)
Glucotrack (GCTK) Cash from Investing Activities Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.99% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.86% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 18.69% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -102.03% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.27% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -7.01% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -3.15% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.22% |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -81.71% |
| Dec 31, 2022 | 136.40% |
| Dec 31, 2021 | -35.40% |
| Sep 30, 2020 | -28.48% |
| Mar 31, 2020 | -116.56% |
| Sep 30, 2019 | 24.07% |
| Jun 30, 2019 | 45.99% |
| Mar 31, 2019 | 35.67% |
| Sep 30, 2018 | 46.28% |
| Jun 30, 2018 | 68.39% |
| Mar 31, 2018 | 57.47% |
| Sep 30, 2017 | 22.68% |
| Jun 30, 2017 | 55.81% |
| Mar 31, 2017 | 44.95% |
| Sep 30, 2016 | -23.24% |
| Jun 30, 2016 | 33.26% |
| Mar 31, 2016 | -212.36% |
| Sep 30, 2015 | -182.87% |
| Jun 30, 2015 | -96.86% |
| Mar 31, 2015 | 7.92% |